Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ondrej Brom"'
Autor:
Igor Richter, Alexandr Poprach, Anezka Zemankova, Tomas Buchler, Jiri Bartos, Vladimir Samal, Hana Studentova, Aneta Rozsypalova, Josef Dvorak, Ondrej Brom, Bohuslav Melichar
Publikováno v:
Biomedical Papers, Vol 166, Iss 1, Pp 97-104 (2022)
Aim. The aim of this study was to retrospectively analyze treatment outcomes and tolerance in patients in whom cabozantinib was used after previous targeted therapy. Patients and Methods. Cabozantinib was administered in dose 60 mg/day, a subset of p
Externí odkaz:
https://doaj.org/article/15cacfbb56434393aa47bcaf504f7acd
Autor:
Alexandr Poprach, Anezka Zemankova, Igor Richter, Bohuslav Melichar, Hana Študentová, Aneta Rozsypalova, Tomas Buchler, Vladimir Samal, Josef Dvorak, Ondrej Brom, Jiri Bartos
Publikováno v:
Biomedical Papers. 166:97-104
Aim The aim of this study was to retrospectively analyze treatment outcomes and tolerance in patients in whom cabozantinib was used after previous targeted therapy. Patients and methods Cabozantinib was administered in dose 60 mg/day, a subset of pat
Autor:
Igor, Richter, Alexandr, Poprach, Anezka, Zemankova, Tomas, Buchler, Jiri, Bartos, Vladimir, Samal, Hana, Studentova, Aneta, Rozsypalova, Josef, Dvorak, Ondrej, Brom, Bohuslav, Melichar
Publikováno v:
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 166(1)
The aim of this study was to retrospectively analyze treatment outcomes and tolerance in patients in whom cabozantinib was used after previous targeted therapy.Cabozantinib was administered in dose 60 mg/day, a subset of patients received initial dos